Filing Flows › OptimizeRx (OPRX) › Free cash flow
OptimizeRx (OPRX) free cash flow by quarter
OptimizeRx's free cash flow was $8.6M in Q2 2026 (second quarter 2026), +21% from Q4 2025. Over the last 6 quarters it ranged from $181K (Q4 2024) to $8.6M (Q2 2026).
| Quarter | Free cash flow | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $8.6M | +21% | +88% |
| Q4 2025 | $7.1M | +122% | 39× |
| Q3 2025 | $3.2M | -30% | — |
| Q2 2025 | $4.6M | +19% | — |
| Q1 2025 | $3.8M | 21× | — |
| Q4 2024 | $181K | — | — |
Q2 2026 at a glance
OptimizeRx, Q2 2026: revenue $20.5M (-30% year over year), operating margin -0.4%, net loss $703K, operating cash flow $8.6M. The chart follows the revenue to costs, profit and cash.
Questions
What is OptimizeRx's free cash flow?
OptimizeRx's free cash flow was $8.6M in Q2 2026 (second quarter 2026), +21% from Q4 2025.
How has OptimizeRx's free cash flow changed?
Over the last 6 quarters it ranged from $181K (Q4 2024) to $8.6M (Q2 2026).